Cargando…

Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis

BACKGROUND: Chinese herbal medicine is widely used in combination with usual care for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China. Chinese patent medicine Shufeng Jiedu (SFJD) capsules is widely used for respiratory infectious diseases. This review aims to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Ru-yu, Hu, Xiao-yang, Fei, Yu-tong, Willcox, Merlin, Wen, Ling-zi, Yu, Ming-kun, Zhang, Li-shan, Dai, Meng-yuan, Fei, Guang-he, Thomas, Mike, Francis, Nick, Wilkinson, Tom, Moore, Michael, Liu, Jian-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245765/ https://www.ncbi.nlm.nih.gov/pubmed/32448238 http://dx.doi.org/10.1186/s12906-020-02924-5

Ejemplares similares

Shufeng Jiedu capsule for acute exacerbation of chronic obstructive pulmonary disease: a protocol of multicentre, randomised, double-blind, placebo-controlled trial
por: Xia, Ruyu, et al.
Publicado: (2023)

Chinese Patent Medicine Shufeng Jiedu Capsules as an Adjuvant Therapy for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis
por: Zhang, Ying-ying, et al.
Publicado: (2021)

Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection
por: Han, Yanqi, et al.
Publicado: (2023)

Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Ren, Huijun, et al.
Publicado: (2021)

Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
por: Xiong, Haijun, et al.
Publicado: (2020)

The add-on effect of Shufeng Jiedu capsule for treating COVID-19: A systematic review and meta-analysis
por: Sheng, Xiaodi, et al.
Publicado: (2022)

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
por: Chen, Xiao, et al.
Publicado: (2020)

Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Ma, Li, et al.
Publicado: (2020)

Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking
por: Simayi, Jimilihan, et al.
Publicado: (2022)

Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI
por: Cai, Junnan, et al.
Publicado: (2022)

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)

Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia
por: Tao, Zhengang, et al.
Publicado: (2020)

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
por: XIA, Lu, et al.
Publicado: (2021)

Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
por: Zhang, Lei, et al.
Publicado: (2020)

Use of antibiotics and other treatments in Chinese adults with acute cough: An online survey
por: Hu, Xiao-Yang, et al.
Publicado: (2023)

Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction
por: Chen, Yue, et al.
Publicado: (2022)

Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis
por: Hoult, George, et al.
Publicado: (2022)

Effects of Huanglian Jiedu Decoration in Rat Gingivitis
por: Zhang, Fangbo, et al.
Publicado: (2018)

Effect of Lianhuaqingwen Capsules on Airway Inflammation in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Liang, et al.
Publicado: (2014)

Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial
por: Hu, Xiao-Yang, et al.
Publicado: (2022)

Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial
por: Willcox, Merlin L., et al.
Publicado: (2023)

Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy
por: Xuan, Chen, et al.
Publicado: (2021)

Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma
por: Xie, Yuqing, et al.
Publicado: (2022)

Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer’s Disease
por: Qi, Yi-Yu, et al.
Publicado: (2022)

Huanglian Jiedu Decoction Exerts Antipyretic Effect by Inhibiting MAPK Signaling Pathway
por: Li, Xing, et al.
Publicado: (2021)

Subchronic toxicity of herbal compound “Jiedu Huayu” granules in rats
por: Wang, Minggang, et al.
Publicado: (2017)

Huayu Jiedu Fang Protects Ovarian Function in Mouse with Endometriosis Iron Overload by Inhibiting Ferroptosis
por: Ding, Jie, et al.
Publicado: (2022)

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
por: Qi, Yu-Jing, et al.
Publicado: (2020)

Network Pharmacology Interpretation of Fuzheng–Jiedu Decoction against Colorectal Cancer
por: Shi, Hongshuo, et al.
Publicado: (2021)

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People’s Republic of China
por: Cai, Bai-qiang, et al.
Publicado: (2014)

Effects of Air Pollutant Exposure on Exacerbation Severity in Asthma Patients with or without Reversible Airflow Obstruction
por: Fang, Wei, et al.
Publicado: (2021)

A Novel Strategy for Decoding and Validating the Combination Principles of Huanglian Jiedu Decoction From Multi-Scale Perspective
por: Wang, Ke-Xin, et al.
Publicado: (2020)

Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways
por: Gu, Li-fei, et al.
Publicado: (2020)

Capsule Commentary on Bremmer et. al., Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations
por: Mathioudakis, Alexander G.
Publicado: (2018)

Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
por: Gong, Zhaohui, et al.
Publicado: (2022)

Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota
por: Wang, Jiale, et al.
Publicado: (2022)

Effect and Molecular Mechanisms of Jiedu Recipe on Hypoxia-Induced Angiogenesis after Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
por: Lin, Wanfu, et al.
Publicado: (2021)

Network pharmacology combined with pharmacodynamics revealed the anti-inflammatory mechanism of Tanreqing capsule against acute-exacerbation chronic obstructive pulmonary disease
por: Han, Xiao-Xiao, et al.
Publicado: (2022)

Predictors of clinical deterioration in patients with suspected COVID-19 managed in a ‘virtual hospital’ setting: a cohort study
por: Francis, Nick A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_238vvhct33dm2f50s73n08qmv3